<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>&#43;Protein subunit on Vishvas&#39;s notes</title>
    <link>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/protein-subunit/</link>
    <description>Recent content in &#43;Protein subunit on Vishvas&#39;s notes</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <atom:link href="https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/protein-subunit/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Novavax</title>
      <link>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/protein-subunit/Novavax/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://vishvAsa.github.io/notes/general_biology/virus/ribo/ortho-rna/corona/wuhan_epidemic/Infection/vaccination/protein-subunit/Novavax/</guid>
      <description>&lt;ul&gt;&#xA;&lt;li&gt;Novavax/ Novavac/ Covovax vaccine&lt;/li&gt;&#xA;&lt;li&gt;Directly injects stabilized spike proteins (mRNA or DNA not used.) This same technology has been used since 1986 with Hep B vaccines that are given to even infants and found extremely safer.&#xA;&lt;ul&gt;&#xA;&lt;li&gt;They took the code for the Spike Protein, put it into another virus called baculovirus that infected moth cells. Spike proteins made were collected, made into nanoparticles, and used as vaccine.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;li&gt;can be stored in warmer temperatures, anywhere between 36°F and 46°F.&lt;/li&gt;&#xA;&lt;li&gt;Serum Institute in India tied up with Novavax and ready to roll out vaccines by July. US blocked raw materials in April.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h2 id=&#34;efficacy&#34;&gt;Efficacy&lt;/h2&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;Overall - 89%, South Africa - 50%&lt;/li&gt;&#xA;&lt;li&gt;Current strain D614G: 95%&lt;/li&gt;&#xA;&lt;li&gt;Against Alpha variant  86%&lt;/li&gt;&#xA;&lt;li&gt;UK strain B1.1.7: 89.3%&lt;/li&gt;&#xA;&lt;li&gt;South African  variant 501Y.V2: 60%&#xA;&lt;ul&gt;&#xA;&lt;li&gt;HIV Neg: 60.1%&lt;/li&gt;&#xA;&lt;li&gt;HIV Pos: 49.4%&lt;/li&gt;&#xA;&lt;li&gt;Severe disease: 100%&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;100% efficacy against moderate to severe disease.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
